Periprocedural Management of Antithrombotics — Do Not Hold if you Can!

The decision to hold or not to hold antithrombotic (AT) medications for an endoscopic procedure rests on the balance of the procedural bleeding risk and the patient ’s risk of suffering a thromboembolic event (TE), including stroke, pulmonary embolism, deep vein thrombosis, angina, or a myocardial infarction. Guidelines have categorized procedures into those with high and low bleeding risk. AT may be continued if the bleeding risk is low. If the bleeding risk is high, AT medications should be held or modified.

Source: Clinical Gastroenterology and Hepatology - January 28, 2023 Category: Gastroenterology Authors: Heiko Pohl Tags: Editorial Source Type: research